Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.040 | 1.000 | 4 | 2012 | 2015 | ||||||
Primary malignant neoplasm
|
1374 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.040 | 1.000 | 4 | 2012 | 2015 | ||||||
Breast Carcinoma
|
2793 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Malignant neoplasm of breast
|
3417 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||
Malignant neoplasm of stomach
|
615 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||
Neoplasm Metastasis
|
327 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Prostate carcinoma
|
1168 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||
Stomach Carcinoma
|
652 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||
Acute leukemia
|
50 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Acute lymphocytic leukemia
|
222 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Bladder Neoplasm
|
281 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Carcinoma of bladder
|
309 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Colorectal Carcinoma
|
1962 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Genitourinary Cancer
|
1 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant neoplasm of urinary bladder
|
316 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Renal Cell Carcinoma
|
288 | 0.695 | 0.320 | 1 | 11262571 | upstream gene variant | G/C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 |